Pepgen Inc (PEPG)

$1.96 +0.04 (2.08%)
Market Cap 146.64M
Revenue (ttm) 0.00
Net Income (ttm) -89.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 490,209
Avg Vol 869,950
Day's Range N/A - N/A
Shares Out 69.17M
Stochastic %K 5%
Beta 1.88
Analysts Strong Sell
Price Target $10.25

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study....

Industry: Biotechnology
Sector: Healthcare
Phone: 781 797 0979
Address:
321 Harrison Avenue, 8th Floor, Boston, United States
Istanbulll
Istanbulll Jul. 20 at 5:04 PM
$PEPG buy buy buy
0 · Reply
GangsterX
GangsterX Jul. 17 at 2:38 PM
$CMPX $FATE $PMVP $CNTX $PEPG good stocksss never lose babyyyy
2 · Reply
Bebbz88
Bebbz88 Jul. 14 at 5:31 PM
$PDYN doubled my position today hoping for a big move from the bottom of the long term trendline. Did the same with $PEPG not long ago and that’s working out pretty good for me
0 · Reply
Istanbulll
Istanbulll Jul. 14 at 9:51 AM
$PEPG ALLTHE WAY UPPP
0 · Reply
Istanbulll
Istanbulll Jul. 13 at 4:52 PM
$PEPG be up and above my dear Samaritan
0 · Reply
Rodmon77
Rodmon77 Jul. 13 at 3:04 PM
$PEPG Runner 🏃‍♀️ Alert ⚠️ 📢
0 · Reply
GangsterX
GangsterX Jul. 11 at 2:50 AM
$PEPG What did i say ? if i say good shix, it will be good shix ok ??
0 · Reply
GangsterX
GangsterX Jul. 11 at 2:47 AM
$FATE $CMPX $PEPG $CNTX $PMVP Looking good huh ? it will go up more... Relax and enjoy the run.. if i pick something, only big $$ in the pocket. Free $$ no need to sign up membership like others shix...
0 · Reply
CosmicMiner
CosmicMiner Jul. 10 at 9:46 PM
"If price is the voice of the stock, volume is how loudly it speaks." Today's heavy hitters with massive relative volume: $AARD (8.7x), $FRMI (5.0x), $PEPG (2.8x), $CRCL (2.4x), and $META (1.9x). This is where the smart money is aggressively positioning. Expect these high-volume setups to trigger massive continuation moves at Monday's open. The full chart scanner results and my top trade setups are live on my profile!
0 · Reply
YouVSYou
YouVSYou Jul. 10 at 7:41 PM
$FRMI 7.17 next $RXT $CLSK $PEPG $HUMA Swings
2 · Reply
Latest News on PEPG
Craig-Hallum bullish on PepGen, initiates with a Buy

2026-06-16T12:51:30.000Z - 5 weeks ago

Craig-Hallum bullish on PepGen, initiates with a Buy

PepGen initiated with a Buy at Craig-Hallum

2026-06-16T11:21:10.000Z - 5 weeks ago

PepGen initiated with a Buy at Craig-Hallum

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program

May 21, 2026, 7:00 AM EDT - 2 months ago

PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program

PepGen files $400M mixed securities shelf

2026-05-19T16:10:09.000Z - 2 months ago

PepGen files $400M mixed securities shelf

PepGen Registration statement: Registration filing

May 18, 2026, 8:00 AM EDT - 2 months ago

PepGen Registration statement: Registration filing

PepGen price target lowered to $4 from $5 at Wedbush

2026-05-13T15:25:32.000Z - 2 months ago

PepGen price target lowered to $4 from $5 at Wedbush

PepGen reports Q1 EPS (26c), consensus (31c)

2026-05-12T21:47:50.000Z - 2 months ago

PepGen reports Q1 EPS (26c), consensus (31c)

PepGen sees cash runway into 2H27

2026-05-12T21:45:06.000Z - 2 months ago

PepGen sees cash runway into 2H27

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

May 12, 2026, 4:05 PM EDT - 2 months ago

PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

PepGen Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 2 months ago

PepGen Quarterly report: Q1 2026

PepGen Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 2 months ago

PepGen Earnings release: Q1 2026

PepGen Slides: Company presentation

May 12, 2026, 7:00 AM EDT - 2 months ago

PepGen Slides: Company presentation

PepGen Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

PepGen Proxy statement: Proxy filing

PepGen Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 3 months ago

PepGen Proxy statement: Proxy filing

PepGen Slides: Company presentation

Apr 17, 2026, 7:00 AM EDT - 3 months ago

PepGen Slides: Company presentation

PepGen Transcript: Study update

Mar 31, 2026, 4:30 PM EDT - 4 months ago

PepGen Transcript: Study update

PepGen Press release: Study update

Mar 31, 2026, 4:30 PM EDT - 4 months ago

PepGen Press release: Study update

PepGen Slides: Study update

Mar 31, 2026, 4:30 PM EDT - 4 months ago

PepGen Slides: Study update

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 31, 2026, 10:33 AM EDT - 4 months ago

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

PepGen down 46% at $2.30 after Phase 2 Freedom trial data

2026-03-30T21:56:04.000Z - 4 months ago

PepGen down 46% at $2.30 after Phase 2 Freedom trial data

PepGen Inc trading resumes

2026-03-30T20:40:11.000Z - 4 months ago

PepGen Inc trading resumes

PepGen reports ‘promising’ topline results from MAD cohort

2026-03-30T20:20:05.000Z - 4 months ago

PepGen reports ‘promising’ topline results from MAD cohort

PepGen Inc trading halted, news pending

2026-03-30T20:07:54.000Z - 4 months ago

PepGen Inc trading halted, news pending

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

Mar 30, 2026, 4:05 PM EDT - 4 months ago

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

PepGen Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:00 PM EDT - 4 months ago

PepGen Transcript: Leerink Global Healthcare Conference 2026

US FDA puts partial clinical hold on PepGen's muscle disease drug trial

Mar 4, 2026, 4:56 PM EST - 5 months ago

US FDA puts partial clinical hold on PepGen's muscle disease drug trial

PepGen Inc trading resumes

2026-03-04T21:39:13.000Z - 5 months ago

PepGen Inc trading resumes

PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1

2026-03-04T21:20:06.000Z - 5 months ago

PepGen announce FDA placed partial clinical hold on Phase 2 trial of PGN-EDODM1

PepGen reports Q4 EPS (27c), consensus (39c)

2026-03-04T21:19:21.000Z - 5 months ago

PepGen reports Q4 EPS (27c), consensus (39c)

PepGen Inc trading halted, news pending

2026-03-04T21:07:39.000Z - 5 months ago

PepGen Inc trading halted, news pending

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

Mar 4, 2026, 4:05 PM EST - 5 months ago

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

PepGen Announces Regulatory Updates on FREEDOM2

Mar 4, 2026, 4:03 PM EST - 5 months ago

PepGen Announces Regulatory Updates on FREEDOM2

PepGen Annual report: Q4 2025

Mar 4, 2026, 4:00 PM EST - 5 months ago

PepGen Annual report: Q4 2025

PepGen Earnings release: Q4 2025

Mar 4, 2026, 4:00 PM EST - 5 months ago

PepGen Earnings release: Q4 2025

PepGen Slides: Company presentation

Mar 4, 2026, 7:00 AM EST - 5 months ago

PepGen Slides: Company presentation

PepGen to Participate in the Leerink Global Healthcare Conference

Mar 3, 2026, 7:00 AM EST - 5 months ago

PepGen to Participate in the Leerink Global Healthcare Conference

Oppenheimer bullish on PepGen, initiates with an Outperform

2026-02-25T13:24:24.000Z - 5 months ago

Oppenheimer bullish on PepGen, initiates with an Outperform

PepGen price target raised to $7 from $6 at Guggenheim

2026-02-18T12:37:42.000Z - 5 months ago

PepGen price target raised to $7 from $6 at Guggenheim

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

Dec 9, 2025, 7:00 AM EST - 8 months ago

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

Dec 8, 2025, 7:00 AM EST - 8 months ago

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

PepGen Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 4:00 PM EST - 8 months ago

PepGen Transcript: Stifel 2025 Healthcare Conference

PepGen Earnings release: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

PepGen Earnings release: Q3 2025

PepGen Quarterly report: Q3 2025

Nov 12, 2025, 8:00 AM EST - 9 months ago

PepGen Quarterly report: Q3 2025

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

Nov 12, 2025, 7:05 AM EST - 9 months ago

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Nov 12, 2025, 7:00 AM EST - 9 months ago

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen Slides: Investor Presentation

Nov 11, 2025, 7:00 AM EST - 9 months ago

PepGen Slides: Investor Presentation

PepGen Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 11:30 AM EST - 9 months ago

PepGen Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

PepGen to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 9 months ago

PepGen to Participate in Upcoming Investor Conferences

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

Oct 2, 2025, 7:00 AM EDT - 10 months ago

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Sep 26, 2025, 4:01 PM EDT - 10 months ago

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

PepGen Announces Pricing of $100 Million Public Offering

Sep 24, 2025, 10:51 PM EDT - 10 months ago

PepGen Announces Pricing of $100 Million Public Offering

PepGen Announces Proposed Public Offering

Sep 24, 2025, 4:21 PM EDT - 10 months ago

PepGen Announces Proposed Public Offering

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

Sep 24, 2025, 4:16 PM EDT - 10 months ago

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

PepGen Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 1 year ago

PepGen Earnings release: Q2 2025

PepGen Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 1 year ago

PepGen Quarterly report: Q2 2025

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 7, 2025, 8:00 AM EDT - 1 year ago

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen Slides: Corporate Presentation

Jun 17, 2025, 11:07 PM EDT - 1 year ago

PepGen Slides: Corporate Presentation

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2025, 10:44 AM EDT - 1 year ago

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

PepGen to discontinue development of experimental Duchenne therapy; shares drop

May 28, 2025, 6:21 PM EDT - 1 year ago

PepGen to discontinue development of experimental Duchenne therapy; shares drop

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

May 28, 2025, 4:05 PM EDT - 1 year ago

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

May 20, 2025, 7:00 AM EDT - 1 year ago

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 8, 2025, 8:00 AM EDT - 1 year ago

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

PepGen Earnings release: Q1 2025

PepGen Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

PepGen Quarterly report: Q1 2025

PepGen Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PepGen Proxy statement: Proxy Filing

PepGen Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PepGen Proxy statement: Proxy Filing

PepGen Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 9, 2025, 1:30 PM EDT - 1 year ago

PepGen Transcript: 24th Annual Needham Virtual Healthcare Conference

PepGen Slides: 24th Annual Needham Virtual Healthcare Conference

Apr 9, 2025, 1:30 PM EDT - 1 year ago

PepGen Slides: 24th Annual Needham Virtual Healthcare Conference

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 4:05 PM EDT - 1 year ago

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Istanbulll
Istanbulll Jul. 20 at 5:04 PM
$PEPG buy buy buy
0 · Reply
GangsterX
GangsterX Jul. 17 at 2:38 PM
$CMPX $FATE $PMVP $CNTX $PEPG good stocksss never lose babyyyy
2 · Reply
Bebbz88
Bebbz88 Jul. 14 at 5:31 PM
$PDYN doubled my position today hoping for a big move from the bottom of the long term trendline. Did the same with $PEPG not long ago and that’s working out pretty good for me
0 · Reply
Istanbulll
Istanbulll Jul. 14 at 9:51 AM
$PEPG ALLTHE WAY UPPP
0 · Reply
Istanbulll
Istanbulll Jul. 13 at 4:52 PM
$PEPG be up and above my dear Samaritan
0 · Reply
Rodmon77
Rodmon77 Jul. 13 at 3:04 PM
$PEPG Runner 🏃‍♀️ Alert ⚠️ 📢
0 · Reply
GangsterX
GangsterX Jul. 11 at 2:50 AM
$PEPG What did i say ? if i say good shix, it will be good shix ok ??
0 · Reply
GangsterX
GangsterX Jul. 11 at 2:47 AM
$FATE $CMPX $PEPG $CNTX $PMVP Looking good huh ? it will go up more... Relax and enjoy the run.. if i pick something, only big $$ in the pocket. Free $$ no need to sign up membership like others shix...
0 · Reply
CosmicMiner
CosmicMiner Jul. 10 at 9:46 PM
"If price is the voice of the stock, volume is how loudly it speaks." Today's heavy hitters with massive relative volume: $AARD (8.7x), $FRMI (5.0x), $PEPG (2.8x), $CRCL (2.4x), and $META (1.9x). This is where the smart money is aggressively positioning. Expect these high-volume setups to trigger massive continuation moves at Monday's open. The full chart scanner results and my top trade setups are live on my profile!
0 · Reply
YouVSYou
YouVSYou Jul. 10 at 7:41 PM
$FRMI 7.17 next $RXT $CLSK $PEPG $HUMA Swings
2 · Reply
Rodmon77
Rodmon77 Jul. 10 at 5:57 PM
$PEPG
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 10 at 1:56 PM
$PEPG Another overnight swing winner... $2.44 To break for more 🚨 🚨
0 · Reply
Istanbulll
Istanbulll Jul. 10 at 9:45 AM
$PEPG READY TO FCK BABY
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Jul. 10 at 1:26 AM
$PEPG It's in the gap we up and should give even more tomorrow as this moves towards $3.00 area🏆🏆
0 · Reply
MrGreenth
MrGreenth Jul. 10 at 12:12 AM
$PEPG on close watch
0 · Reply
Rodmon77
Rodmon77 Jul. 9 at 9:42 PM
$PEPG Ripper Potential ✨️🔥
0 · Reply
CosmicMiner
CosmicMiner Jul. 9 at 8:58 PM
Relative Volume EXPLOSION! Smart money is aggressively loading the boat on 7/9! Volume is the ultimate truth. Institutional orders are heavily hitting the tape across my top 5 high-conviction setups: $CNTB (4.0x RVOL) $PEPG (3.6x RVOL) leading the charge $LASR (2.7x) $GTLB (2.4x) $MARA (1.8x) Massive block trades are clearing out the ask. Momentum is coiling for a massive structural expansion! Full volume profile analysis and key algorithmic entry levels pinned on my profile. The next list is coming soon! Are you going to miss it again?
0 · Reply
Istanbulll
Istanbulll Jul. 9 at 8:47 PM
$PEPG give me baby one more timeeee
0 · Reply
Bebbz88
Bebbz88 Jul. 9 at 8:15 PM
$PEPG 3 weeks left will we make it
0 · Reply
kubota2323
kubota2323 Jul. 9 at 7:20 PM
$PEPG Oxford Science Enterprises plc Former 10% Owner Sep 30 '25 Buy 3.20 200,000 640,000 4,955,388 Oct 01 01:07 PM RA CAPITAL MANAGEMENT, L.P. Director Sep 26 '25 Buy 3.20 9,375,000 30,000,000 18,554,273 Sep 30 04:35 PM
0 · Reply
potrero
potrero Jul. 9 at 6:10 PM
$PEPG
0 · Reply